C-X-Cケモカイン受容体タイプ1の世界市場（～2026年）

• 英文タイトル：Global C-X-C Chemokine Receptor Type 1 Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY00810 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はC-X-Cケモカイン受容体タイプ1のグローバル市場について調査・分析したレポートです。種類別（DF-2755A、PAC-G31P、レパリキシン、SX-576、その他）市場規模、用途別（炎症、肺がん、黒色腫、術後痛、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別C-X-Cケモカイン受容体タイプ1の競争状況、市場シェア ・世界のC-X-Cケモカイン受容体タイプ1市場：種類別市場規模 2015年-2020年（DF-2755A、PAC-G31P、レパリキシン、SX-576、その他） ・世界のC-X-Cケモカイン受容体タイプ1市場：種類別市場規模予測 2021年-2026年（DF-2755A、PAC-G31P、レパリキシン、SX-576、その他） ・世界のC-X-Cケモカイン受容体タイプ1市場：用途別市場規模 2015年-2020年（炎症、肺がん、黒色腫、術後痛、その他） ・世界のC-X-Cケモカイン受容体タイプ1市場：用途別市場規模予測 2021年-2026年（炎症、肺がん、黒色腫、術後痛、その他） ・北米のC-X-Cケモカイン受容体タイプ1市場分析：米国、カナダ ・ヨーロッパのC-X-Cケモカイン受容体タイプ1市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのC-X-Cケモカイン受容体タイプ1市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のC-X-Cケモカイン受容体タイプ1市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのC-X-Cケモカイン受容体タイプ1市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Dompe Farmaceutici SpA、Syntrix Biosystems Inc、Vaccibody AS ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global C-X-C Chemokine Receptor Type 1 Market
The global C-X-C Chemokine Receptor Type 1 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global C-X-C Chemokine Receptor Type 1 Scope and Market Size
C-X-C Chemokine Receptor Type 1 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global C-X-C Chemokine Receptor Type 1 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the C-X-C Chemokine Receptor Type 1 market is segmented into
DF-2755A
PAC-G31P
Reparixin
SX-576
Others

Segment by Application, the C-X-C Chemokine Receptor Type 1 market is segmented into
Inflammation
Lung Cancer
Melanoma
Post-Operative Pain
Others

Regional and Country-level Analysis
The C-X-C Chemokine Receptor Type 1 market is analysed and market size information is provided by regions (countries).
The key regions covered in the C-X-C Chemokine Receptor Type 1 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and C-X-C Chemokine Receptor Type 1 Market Share Analysis
C-X-C Chemokine Receptor Type 1 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in C-X-C Chemokine Receptor Type 1 business, the date to enter into the C-X-C Chemokine Receptor Type 1 market, C-X-C Chemokine Receptor Type 1 product introduction, recent developments, etc.

The major vendors covered:
Dompe Farmaceutici SpA
Syntrix Biosystems Inc
Vaccibody AS
…

レポート目次

---

1 Study Coverage
1.1 C-X-C Chemokine Receptor Type 1 Product Introduction
1.2 Market Segments
1.3 Key C-X-C Chemokine Receptor Type 1 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global C-X-C Chemokine Receptor Type 1 Market Size Growth Rate by Type
1.4.2 DF-2755A
1.4.3 PAC-G31P
1.4.4 Reparixin
1.4.5 SX-576
1.4.6 Others
1.5 Market by Application
1.5.1 Global C-X-C Chemokine Receptor Type 1 Market Size Growth Rate by Application
1.5.2 Inflammation
1.5.3 Lung Cancer
1.5.4 Melanoma
1.5.5 Post-Operative Pain
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global C-X-C Chemokine Receptor Type 1 Market Size, Estimates and Forecasts
2.1.1 Global C-X-C Chemokine Receptor Type 1 Revenue 2015-2026
2.1.2 Global C-X-C Chemokine Receptor Type 1 Sales 2015-2026
2.2 Global C-X-C Chemokine Receptor Type 1, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global C-X-C Chemokine Receptor Type 1 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global C-X-C Chemokine Receptor Type 1 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global C-X-C Chemokine Receptor Type 1 Competitor Landscape by Players
3.1 C-X-C Chemokine Receptor Type 1 Sales by Manufacturers
3.1.1 C-X-C Chemokine Receptor Type 1 Sales by Manufacturers (2015-2020)
3.1.2 C-X-C Chemokine Receptor Type 1 Sales Market Share by Manufacturers (2015-2020)
3.2 C-X-C Chemokine Receptor Type 1 Revenue by Manufacturers
3.2.1 C-X-C Chemokine Receptor Type 1 Revenue by Manufacturers (2015-2020)
3.2.2 C-X-C Chemokine Receptor Type 1 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global C-X-C Chemokine Receptor Type 1 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by C-X-C Chemokine Receptor Type 1 Revenue in 2019
3.2.5 Global C-X-C Chemokine Receptor Type 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 C-X-C Chemokine Receptor Type 1 Price by Manufacturers
3.4 C-X-C Chemokine Receptor Type 1 Manufacturing Base Distribution, Product Types
3.4.1 C-X-C Chemokine Receptor Type 1 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers C-X-C Chemokine Receptor Type 1 Product Type
3.4.3 Date of International Manufacturers Enter into C-X-C Chemokine Receptor Type 1 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global C-X-C Chemokine Receptor Type 1 Market Size by Type (2015-2020)
4.1.1 Global C-X-C Chemokine Receptor Type 1 Sales by Type (2015-2020)
4.1.2 Global C-X-C Chemokine Receptor Type 1 Revenue by Type (2015-2020)
4.1.3 C-X-C Chemokine Receptor Type 1 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global C-X-C Chemokine Receptor Type 1 Market Size Forecast by Type (2021-2026)
4.2.1 Global C-X-C Chemokine Receptor Type 1 Sales Forecast by Type (2021-2026)
4.2.2 Global C-X-C Chemokine Receptor Type 1 Revenue Forecast by Type (2021-2026)
4.2.3 C-X-C Chemokine Receptor Type 1 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global C-X-C Chemokine Receptor Type 1 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global C-X-C Chemokine Receptor Type 1 Market Size by Application (2015-2020)
5.1.1 Global C-X-C Chemokine Receptor Type 1 Sales by Application (2015-2020)
5.1.2 Global C-X-C Chemokine Receptor Type 1 Revenue by Application (2015-2020)
5.1.3 C-X-C Chemokine Receptor Type 1 Price by Application (2015-2020)
5.2 C-X-C Chemokine Receptor Type 1 Market Size Forecast by Application (2021-2026)
5.2.1 Global C-X-C Chemokine Receptor Type 1 Sales Forecast by Application (2021-2026)
5.2.2 Global C-X-C Chemokine Receptor Type 1 Revenue Forecast by Application (2021-2026)
5.2.3 Global C-X-C Chemokine Receptor Type 1 Price Forecast by Application (2021-2026)

6 North America
6.1 North America C-X-C Chemokine Receptor Type 1 by Country
6.1.1 North America C-X-C Chemokine Receptor Type 1 Sales by Country
6.1.2 North America C-X-C Chemokine Receptor Type 1 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America C-X-C Chemokine Receptor Type 1 Market Facts & Figures by Type
6.3 North America C-X-C Chemokine Receptor Type 1 Market Facts & Figures by Application

7 Europe
7.1 Europe C-X-C Chemokine Receptor Type 1 by Country
7.1.1 Europe C-X-C Chemokine Receptor Type 1 Sales by Country
7.1.2 Europe C-X-C Chemokine Receptor Type 1 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe C-X-C Chemokine Receptor Type 1 Market Facts & Figures by Type
7.3 Europe C-X-C Chemokine Receptor Type 1 Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific C-X-C Chemokine Receptor Type 1 by Region
8.1.1 Asia Pacific C-X-C Chemokine Receptor Type 1 Sales by Region
8.1.2 Asia Pacific C-X-C Chemokine Receptor Type 1 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific C-X-C Chemokine Receptor Type 1 Market Facts & Figures by Type
8.3 Asia Pacific C-X-C Chemokine Receptor Type 1 Market Facts & Figures by Application

9 Latin America
9.1 Latin America C-X-C Chemokine Receptor Type 1 by Country
9.1.1 Latin America C-X-C Chemokine Receptor Type 1 Sales by Country
9.1.2 Latin America C-X-C Chemokine Receptor Type 1 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America C-X-C Chemokine Receptor Type 1 Market Facts & Figures by Type
9.3 Central & South America C-X-C Chemokine Receptor Type 1 Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa C-X-C Chemokine Receptor Type 1 by Country
10.1.1 Middle East and Africa C-X-C Chemokine Receptor Type 1 Sales by Country
10.1.2 Middle East and Africa C-X-C Chemokine Receptor Type 1 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa C-X-C Chemokine Receptor Type 1 Market Facts & Figures by Type
10.3 Middle East and Africa C-X-C Chemokine Receptor Type 1 Market Facts & Figures by Application

11 Company Profiles
11.1 Dompe Farmaceutici SpA
11.1.1 Dompe Farmaceutici SpA Corporation Information
11.1.2 Dompe Farmaceutici SpA Description and Business Overview
11.1.3 Dompe Farmaceutici SpA Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 1 Products Offered
11.1.5 Dompe Farmaceutici SpA Related Developments
11.2 Syntrix Biosystems Inc
11.2.1 Syntrix Biosystems Inc Corporation Information
11.2.2 Syntrix Biosystems Inc Description and Business Overview
11.2.3 Syntrix Biosystems Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 1 Products Offered
11.2.5 Syntrix Biosystems Inc Related Developments
11.3 Vaccibody AS
11.3.1 Vaccibody AS Corporation Information
11.3.2 Vaccibody AS Description and Business Overview
11.3.3 Vaccibody AS Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Vaccibody AS C-X-C Chemokine Receptor Type 1 Products Offered
11.3.5 Vaccibody AS Related Developments
11.1 Dompe Farmaceutici SpA
11.1.1 Dompe Farmaceutici SpA Corporation Information
11.1.2 Dompe Farmaceutici SpA Description and Business Overview
11.1.3 Dompe Farmaceutici SpA Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 1 Products Offered
11.1.5 Dompe Farmaceutici SpA Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 C-X-C Chemokine Receptor Type 1 Market Estimates and Projections by Region
12.1.1 Global C-X-C Chemokine Receptor Type 1 Sales Forecast by Regions 2021-2026
12.1.2 Global C-X-C Chemokine Receptor Type 1 Revenue Forecast by Regions 2021-2026
12.2 North America C-X-C Chemokine Receptor Type 1 Market Size Forecast (2021-2026)
12.2.1 North America: C-X-C Chemokine Receptor Type 1 Sales Forecast (2021-2026)
12.2.2 North America: C-X-C Chemokine Receptor Type 1 Revenue Forecast (2021-2026)
12.2.3 North America: C-X-C Chemokine Receptor Type 1 Market Size Forecast by Country (2021-2026)
12.3 Europe C-X-C Chemokine Receptor Type 1 Market Size Forecast (2021-2026)
12.3.1 Europe: C-X-C Chemokine Receptor Type 1 Sales Forecast (2021-2026)
12.3.2 Europe: C-X-C Chemokine Receptor Type 1 Revenue Forecast (2021-2026)
12.3.3 Europe: C-X-C Chemokine Receptor Type 1 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific C-X-C Chemokine Receptor Type 1 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: C-X-C Chemokine Receptor Type 1 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: C-X-C Chemokine Receptor Type 1 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: C-X-C Chemokine Receptor Type 1 Market Size Forecast by Region (2021-2026)
12.5 Latin America C-X-C Chemokine Receptor Type 1 Market Size Forecast (2021-2026)
12.5.1 Latin America: C-X-C Chemokine Receptor Type 1 Sales Forecast (2021-2026)
12.5.2 Latin America: C-X-C Chemokine Receptor Type 1 Revenue Forecast (2021-2026)
12.5.3 Latin America: C-X-C Chemokine Receptor Type 1 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa C-X-C Chemokine Receptor Type 1 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: C-X-C Chemokine Receptor Type 1 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: C-X-C Chemokine Receptor Type 1 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: C-X-C Chemokine Receptor Type 1 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key C-X-C Chemokine Receptor Type 1 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 C-X-C Chemokine Receptor Type 1 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. C-X-C Chemokine Receptor Type 1 Market Segments
Table 2. Ranking of Global Top C-X-C Chemokine Receptor Type 1 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global C-X-C Chemokine Receptor Type 1 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of DF-2755A
Table 5. Major Manufacturers of PAC-G31P
Table 6. Major Manufacturers of Reparixin
Table 7. Major Manufacturers of SX-576
Table 8. Major Manufacturers of Others
Table 9. Global C-X-C Chemokine Receptor Type 1 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global C-X-C Chemokine Receptor Type 1 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global C-X-C Chemokine Receptor Type 1 Sales by Regions 2015-2020 (K Pcs)
Table 12. Global C-X-C Chemokine Receptor Type 1 Sales Market Share by Regions (2015-2020)
Table 13. Global C-X-C Chemokine Receptor Type 1 Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global C-X-C Chemokine Receptor Type 1 Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global C-X-C Chemokine Receptor Type 1 Sales Share by Manufacturers (2015-2020)
Table 16. Global C-X-C Chemokine Receptor Type 1 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global C-X-C Chemokine Receptor Type 1 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in C-X-C Chemokine Receptor Type 1 as of 2019)
Table 18. C-X-C Chemokine Receptor Type 1 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. C-X-C Chemokine Receptor Type 1 Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers C-X-C Chemokine Receptor Type 1 Price (2015-2020) (USD/Pcs)
Table 21. C-X-C Chemokine Receptor Type 1 Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers C-X-C Chemokine Receptor Type 1 Product Type
Table 23. Date of International Manufacturers Enter into C-X-C Chemokine Receptor Type 1 Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global C-X-C Chemokine Receptor Type 1 Sales by Type (2015-2020) (K Pcs)
Table 26. Global C-X-C Chemokine Receptor Type 1 Sales Share by Type (2015-2020)
Table 27. Global C-X-C Chemokine Receptor Type 1 Revenue by Type (2015-2020) (US$ Million)
Table 28. Global C-X-C Chemokine Receptor Type 1 Revenue Share by Type (2015-2020)
Table 29. C-X-C Chemokine Receptor Type 1 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global C-X-C Chemokine Receptor Type 1 Sales by Application (2015-2020) (K Pcs)
Table 31. Global C-X-C Chemokine Receptor Type 1 Sales Share by Application (2015-2020)
Table 32. North America C-X-C Chemokine Receptor Type 1 Sales by Country (2015-2020) (K Pcs)
Table 33. North America C-X-C Chemokine Receptor Type 1 Sales Market Share by Country (2015-2020)
Table 34. North America C-X-C Chemokine Receptor Type 1 Revenue by Country (2015-2020) (US$ Million)
Table 35. North America C-X-C Chemokine Receptor Type 1 Revenue Market Share by Country (2015-2020)
Table 36. North America C-X-C Chemokine Receptor Type 1 Sales by Type (2015-2020) (K Pcs)
Table 37. North America C-X-C Chemokine Receptor Type 1 Sales Market Share by Type (2015-2020)
Table 38. North America C-X-C Chemokine Receptor Type 1 Sales by Application (2015-2020) (K Pcs)
Table 39. North America C-X-C Chemokine Receptor Type 1 Sales Market Share by Application (2015-2020)
Table 40. Europe C-X-C Chemokine Receptor Type 1 Sales by Country (2015-2020) (K Pcs)
Table 41. Europe C-X-C Chemokine Receptor Type 1 Sales Market Share by Country (2015-2020)
Table 42. Europe C-X-C Chemokine Receptor Type 1 Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe C-X-C Chemokine Receptor Type 1 Revenue Market Share by Country (2015-2020)
Table 44. Europe C-X-C Chemokine Receptor Type 1 Sales by Type (2015-2020) (K Pcs)
Table 45. Europe C-X-C Chemokine Receptor Type 1 Sales Market Share by Type (2015-2020)
Table 46. Europe C-X-C Chemokine Receptor Type 1 Sales by Application (2015-2020) (K Pcs)
Table 47. Europe C-X-C Chemokine Receptor Type 1 Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific C-X-C Chemokine Receptor Type 1 Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific C-X-C Chemokine Receptor Type 1 Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific C-X-C Chemokine Receptor Type 1 Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific C-X-C Chemokine Receptor Type 1 Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific C-X-C Chemokine Receptor Type 1 Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific C-X-C Chemokine Receptor Type 1 Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific C-X-C Chemokine Receptor Type 1 Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific C-X-C Chemokine Receptor Type 1 Sales Market Share by Application (2015-2020)
Table 56. Latin America C-X-C Chemokine Receptor Type 1 Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America C-X-C Chemokine Receptor Type 1 Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa C-X-C Chemokine Receptor Type 1 Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America C-X-C Chemokine Receptor Type 1 Revenue Market Share by Country (2015-2020)
Table 60. Latin America C-X-C Chemokine Receptor Type 1 Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America C-X-C Chemokine Receptor Type 1 Sales Market Share by Type (2015-2020)
Table 62. Latin America C-X-C Chemokine Receptor Type 1 Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America C-X-C Chemokine Receptor Type 1 Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa C-X-C Chemokine Receptor Type 1 Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa C-X-C Chemokine Receptor Type 1 Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa C-X-C Chemokine Receptor Type 1 Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa C-X-C Chemokine Receptor Type 1 Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa C-X-C Chemokine Receptor Type 1 Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa C-X-C Chemokine Receptor Type 1 Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa C-X-C Chemokine Receptor Type 1 Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa C-X-C Chemokine Receptor Type 1 Sales Market Share by Application (2015-2020)
Table 72. Dompe Farmaceutici SpA Corporation Information
Table 73. Dompe Farmaceutici SpA Description and Major Businesses
Table 74. Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Dompe Farmaceutici SpA Product
Table 76. Dompe Farmaceutici SpA Recent Development
Table 77. Syntrix Biosystems Inc Corporation Information
Table 78. Syntrix Biosystems Inc Description and Major Businesses
Table 79. Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Syntrix Biosystems Inc Product
Table 81. Syntrix Biosystems Inc Recent Development
Table 82. Vaccibody AS Corporation Information
Table 83. Vaccibody AS Description and Major Businesses
Table 84. Vaccibody AS C-X-C Chemokine Receptor Type 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Vaccibody AS Product
Table 86. Vaccibody AS Recent Development
Table 87. Global C-X-C Chemokine Receptor Type 1 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 88. Global C-X-C Chemokine Receptor Type 1 Sales Market Share Forecast by Regions (2021-2026)
Table 89. Global C-X-C Chemokine Receptor Type 1 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 90. Global C-X-C Chemokine Receptor Type 1 Revenue Market Share Forecast by Regions (2021-2026)
Table 91. North America: C-X-C Chemokine Receptor Type 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 92. North America: C-X-C Chemokine Receptor Type 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 93. Europe: C-X-C Chemokine Receptor Type 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 94. Europe: C-X-C Chemokine Receptor Type 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 95. Asia Pacific: C-X-C Chemokine Receptor Type 1 Sales Forecast by Region (2021-2026) (K Pcs)
Table 96. Asia Pacific: C-X-C Chemokine Receptor Type 1 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 97. Latin America: C-X-C Chemokine Receptor Type 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 98. Latin America: C-X-C Chemokine Receptor Type 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 99. Middle East and Africa: C-X-C Chemokine Receptor Type 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 100. Middle East and Africa: C-X-C Chemokine Receptor Type 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 102. Key Challenges
Table 103. Market Risks
Table 104. Main Points Interviewed from Key C-X-C Chemokine Receptor Type 1 Players
Table 105. C-X-C Chemokine Receptor Type 1 Customers List
Table 106. C-X-C Chemokine Receptor Type 1 Distributors List
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. C-X-C Chemokine Receptor Type 1 Product Picture
Figure 2. Global C-X-C Chemokine Receptor Type 1 Sales Market Share by Type in 2020 & 2026
Figure 3. DF-2755A Product Picture
Figure 4. PAC-G31P Product Picture
Figure 5. Reparixin Product Picture
Figure 6. SX-576 Product Picture
Figure 7. Others Product Picture
Figure 8. Global C-X-C Chemokine Receptor Type 1 Sales Market Share by Application in 2020 & 2026
Figure 9. Inflammation
Figure 10. Lung Cancer
Figure 11. Melanoma
Figure 12. Post-Operative Pain
Figure 13. Others
Figure 14. C-X-C Chemokine Receptor Type 1 Report Years Considered
Figure 15. Global C-X-C Chemokine Receptor Type 1 Market Size 2015-2026 (US$ Million)
Figure 16. Global C-X-C Chemokine Receptor Type 1 Sales 2015-2026 (K Pcs)
Figure 17. Global C-X-C Chemokine Receptor Type 1 Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global C-X-C Chemokine Receptor Type 1 Sales Market Share by Region (2015-2020)
Figure 19. Global C-X-C Chemokine Receptor Type 1 Sales Market Share by Region in 2019
Figure 20. Global C-X-C Chemokine Receptor Type 1 Revenue Market Share by Region (2015-2020)
Figure 21. Global C-X-C Chemokine Receptor Type 1 Revenue Market Share by Region in 2019
Figure 22. Global C-X-C Chemokine Receptor Type 1 Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by C-X-C Chemokine Receptor Type 1 Revenue in 2019
Figure 24. C-X-C Chemokine Receptor Type 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global C-X-C Chemokine Receptor Type 1 Sales Market Share by Type (2015-2020)
Figure 26. Global C-X-C Chemokine Receptor Type 1 Sales Market Share by Type in 2019
Figure 27. Global C-X-C Chemokine Receptor Type 1 Revenue Market Share by Type (2015-2020)
Figure 28. Global C-X-C Chemokine Receptor Type 1 Revenue Market Share by Type in 2019
Figure 29. Global C-X-C Chemokine Receptor Type 1 Market Share by Price Range (2015-2020)
Figure 30. Global C-X-C Chemokine Receptor Type 1 Sales Market Share by Application (2015-2020)
Figure 31. Global C-X-C Chemokine Receptor Type 1 Sales Market Share by Application in 2019
Figure 32. Global C-X-C Chemokine Receptor Type 1 Revenue Market Share by Application (2015-2020)
Figure 33. Global C-X-C Chemokine Receptor Type 1 Revenue Market Share by Application in 2019
Figure 34. North America C-X-C Chemokine Receptor Type 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America C-X-C Chemokine Receptor Type 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America C-X-C Chemokine Receptor Type 1 Sales Market Share by Country in 2019
Figure 37. North America C-X-C Chemokine Receptor Type 1 Revenue Market Share by Country in 2019
Figure 38. U.S. C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America C-X-C Chemokine Receptor Type 1 Market Share by Type in 2019
Figure 43. North America C-X-C Chemokine Receptor Type 1 Market Share by Application in 2019
Figure 44. Europe C-X-C Chemokine Receptor Type 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe C-X-C Chemokine Receptor Type 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe C-X-C Chemokine Receptor Type 1 Sales Market Share by Country in 2019
Figure 47. Europe C-X-C Chemokine Receptor Type 1 Revenue Market Share by Country in 2019
Figure 48. Germany C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe C-X-C Chemokine Receptor Type 1 Market Share by Type in 2019
Figure 59. Europe C-X-C Chemokine Receptor Type 1 Market Share by Application in 2019
Figure 60. Asia Pacific C-X-C Chemokine Receptor Type 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific C-X-C Chemokine Receptor Type 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific C-X-C Chemokine Receptor Type 1 Sales Market Share by Region in 2019
Figure 63. Asia Pacific C-X-C Chemokine Receptor Type 1 Revenue Market Share by Region in 2019
Figure 64. China C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific C-X-C Chemokine Receptor Type 1 Market Share by Type in 2019
Figure 87. Asia Pacific C-X-C Chemokine Receptor Type 1 Market Share by Application in 2019
Figure 88. Latin America C-X-C Chemokine Receptor Type 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America C-X-C Chemokine Receptor Type 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America C-X-C Chemokine Receptor Type 1 Sales Market Share by Country in 2019
Figure 91. Latin America C-X-C Chemokine Receptor Type 1 Revenue Market Share by Country in 2019
Figure 92. Mexico C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America C-X-C Chemokine Receptor Type 1 Market Share by Type in 2019
Figure 99. Latin America C-X-C Chemokine Receptor Type 1 Market Share by Application in 2019
Figure 100. Middle East and Africa C-X-C Chemokine Receptor Type 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa C-X-C Chemokine Receptor Type 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa C-X-C Chemokine Receptor Type 1 Sales Market Share by Country in 2019
Figure 103. Middle East and Africa C-X-C Chemokine Receptor Type 1 Revenue Market Share by Country in 2019
Figure 104. Turkey C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E C-X-C Chemokine Receptor Type 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E C-X-C Chemokine Receptor Type 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa C-X-C Chemokine Receptor Type 1 Market Share by Type in 2019
Figure 111. Middle East and Africa C-X-C Chemokine Receptor Type 1 Market Share by Application in 2019
Figure 112. North America C-X-C Chemokine Receptor Type 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America C-X-C Chemokine Receptor Type 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe C-X-C Chemokine Receptor Type 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe C-X-C Chemokine Receptor Type 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific C-X-C Chemokine Receptor Type 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific C-X-C Chemokine Receptor Type 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America C-X-C Chemokine Receptor Type 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America C-X-C Chemokine Receptor Type 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa C-X-C Chemokine Receptor Type 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa C-X-C Chemokine Receptor Type 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed

---